Loading…

Protocol - Perception of Tobacco Product Risk - Smokeless Tobacco

Add to My Toolkit
Description

This protocol includes questions from Waves 1 and 3 of the Adult Population Assessment of Tobacco and Health Study survey instrument. These specific questions are used to measure a respondent’s perception about the perceived risk of using smokeless tobacco products. The three response categories range from less harmful to more harmful.

Specific Instructions

The Smoking Cessation, Harm Reduction, and Biomarkers Working Group recommends categorizing respondents based on the following reported use characteristics: (1) ever user versus never user; (2) current established user, defined as everyday user or some-day user; and (3) former established user according to the Use of Tobacco Products protocol. Polyuse with other tobacco products should be considered as well.

Current and former users might also be categorized based on type of smokeless tobacco product used: moist snuff (with and without pouch), snus (with and without pouch), and chewing/plug tobacco. As new oral smokeless tobacco products emerge (e.g., tobacco-free nicotine smokeless products, lozenges), investigators should consider their inclusion as well.  

Protocol

Smokeless Tobacco

The next questions ask about smokeless tobacco which you put in your mouth. Frequently you chew, suck or spit while using smokeless tobacco, although there is no need to do so for some types. Snus, for instance, is a type of smokeless tobacco that comes in a small pouch that you put inside your lip.

There are many kinds of smokeless tobacco, such as snus pouches, loose snus, moist snuff, dip, spit, and chewing tobacco. Common brands include Red man®1, Levi Garrett®2, Beech-nut®3, Skoal®4, Grizzly®5, Nordic Ice®6, and Copenhagen®7.

[SHOW GENERIC IMAGES OF SMOKELESS TOBACCO]

1. Have you ever seen or heard of smokeless tobacco, such as snus pouches, loose snus, moist snuff, dip, spit, or chewing tobacco, before this study?

1[ ]Yes

2[ ]No

-8[ ]DONT KNOW

-7[ ]REFUSED

ASK: All respondents

[SHOW GENERIC IMAGES OF SMOKELESS TOBACCO]

2. Is using smokeless tobacco less harmful, about the same, or more harmful than smoking cigarettes? [SHOW IMAGE OF SMOKELESS/SNUS]

1[ ]Less harmful

2[ ]About the same

3[ ]More harmful

-8[ ]DONT KNOW

-7[ ]REFUSED

ASK: Respondents who have seen or heard of smokeless tobacco (Q1=1).

3. Is using snus pouches less harmful, about the same, or more harmful than smoking cigarettes?

1[ ]Less harmful

2[ ]About the same

3[ ]More harmful

-8[ ]DONT KNOW

-7[ ]REFUSED

ASK: All adult respondents.

DISPLAY: UNDERLINE "snus pouches" AND "cigarettes".

4. Is using snus less harmful, about the same, or more harmful than other types of smokeless tobacco products (such as dip, spit or chew)?

1[ ]Less harmful

2[ ]About the same

3[ ]More harmful

-8[ ]DONT KNOW

-7[ ]REFUSED

ASK: All adult respondents.

DISPLAY: UNDERLINE "snus" AND "other types of smokeless tobacco products".

1 Pinkerton Tobacco Co. L.P.
2 Rosswil LLC
3 National Tobacco Company, L.P.
4 U.S. Smokeless Tobacco Company LLC
5 Rosswil, LLC
6 Nordic American Smokeless, Inc.
7 United States Tobacco Manufacturing Limited Partnership

Availability

Available

Personnel and Training Required

None

Equipment Needs

The PhenX Working Group acknowledges that these questions can be administered in a computerized or noncomputerized format (i.e., paper-and-pencil instrument). Computer software is necessary to develop computer-assisted instruments. The interviewer will require a laptop computer/handheld computer to administer a computer-assisted questionnaire.

Requirements
Requirement CategoryRequired
Major equipment No
Specialized training No
Specialized requirements for biospecimen collection No
Average time of greater than 15 minutes in an unaffected individual No
Mode of Administration

Interviewer-administered questionnaire

Lifestage

Adolescent, Adult

Participants

Adult (aged 18 or older)

Adolescent (aged 12-17)

Selection Rationale

The Population Assessment of Tobacco and Health (PATH) Study is a nationally representative, in-person longitudinal cohort study of nonusers and users of tobacco products and those at risk for tobacco use across the United States. Respondents aged 12 years or older are asked questions on tobacco use, attitudes, and health, and biospecimens (buccal cell, urine, and blood) are collected from adults. The PATH Study was implemented to provide an evidence base for assessing and monitoring the Food and Drug Administration’s regulatory actions in meeting its mandate under the Family Smoking Prevention and Tobacco Control Act. Regulatory domains include product standards, new and modified risk products, health warnings, and health education campaigns.

Language

English, Spanish

Standards
StandardNameIDSource
caDSR Common Data Elements (CDE) Smoking PATH Smokeless Tobacco Risk Perception Questionnaire 1 Seen Yes No Unknown Refused Indicator   7582559 CDE Browser
caDSR Common Data Elements (CDE) Smoking PATH Smokeless Tobacco Risk Perception Questionnaire 2 Use Harmfulness Category   7582563 CDE Browser
caDSR Common Data Elements (CDE) Smoking PATH Snus Risk Perception Questionnaire 3 Cigarette Comparison Use Harmfulness Category   7582567 CDE Browser
caDSR Common Data Elements (CDE) Smoking PATH Snus Risk Perception Questionnaire 4 Other Smokeless Tobacco Comparison Use Harmfulness Category 7582571 CDE Browser
Human Phenotype Ontology Addictive behavior HP:0030858 HPO
Derived Variables

None

Process and Review

Not Applicable

Protocol Name from Source

Population Assessment of Tobacco and Health (PATH) Study, PATH Waves 1 and 3 Adult Annotated Instrument, 2016-2018

Source

U.S. Department of Health and Human Services, National Institutes of Health, National Institute on Drug Abuse; and U.S. Department of Health and Human Services, Food and Drug Administration, Center for Tobacco Products, Population Assessment of Tobacco and Health (PATH) Study, 2016, Wave 1 Adult Annotated Instrument, items AS1001, AS1105. Distributed October 21, 2020, by Inter-university Consortium for Political and Social Research, Ann Arbor, MI.

U.S. Department of Health and Human Services, National Institutes of Health, National Institute on Drug Abuse; and U.S. Department of Health and Human Services, Food and Drug Administration, Center for Tobacco Products, Population Assessment of Tobacco and Health (PATH) Study, 2018, Wave 3 Adult Annotated Instrument, items AU1105, AU9040. Distributed October 21, 2020, by Inter-university Consortium for Political and Social Research, Ann Arbor, MI.

General References

Elton-Marshall, T., Driezen, P., Fong, G. T., Cummings, K. M., Persoskie, A., Wackowski, O., Choi, K., Kaufman, A., Strong, D., Gravely, S., Taylor, K., Kwan, J., Bansal-Travers, M., Travers, M., & Hyland, A. (2020). Adult perceptions of the relative harm of tobacco products and subsequent tobacco product use: Longitudinal findings from waves 1 and 2 of the Population Assessment of Tobacco and Health (PATH) Study. Addictive Behaviors, 106, 106337.

Fong, G. T., Elton-Marshall, T., Driezen, P., Kaufman, A. R., Cummings, K. M., Choi, K., Kwan, J., Koblitz, A., Hyland, A., Bansal-Travers, M., Carusi, C., & Thompson, M. E. (2019). U.S. adult perceptions of the harmfulness of tobacco products: descriptive findings from the 2013-14 baseline wave 1 of the PATH Study. Addictive Behaviors, 91, 180-187.

Protocol ID

330505

Variables
Export Variables
Variable Name Variable IDVariable DescriptiondbGaP Mapping
PX330505_Perception_Risk_Smokeless_Ever
PX330505010000 Have you ever seen or heard of smokeless more
tobacco, such as snus pouches, loose snus, moist snuff, dip, spit, or chewing tobacco, before this study? show less
N/A
PX330505_Perception_Risk_Smokeless_Harmful
PX330505020000 Is using smokeless tobacco less harmful, more
about the same, or more harmful than smoking cigarettes? show less
N/A
PX330505_Perception_Risk_Smokeless_Snus_Pouches_Harmful
PX330505030000 Is using snus pouches less harmful, about more
the same, or more harmful than smoking cigarettes? show less
N/A
PX330505_Perception_Risk_Smokeless_Snus_Pouches_Harmful_Other_Product
PX330505040000 Is using snus less harmful, about the same, more
or more harmful than other types of smokeless tobacco products (such as dip, spit or chew)? show less
N/A
Smoking Cessation, Harm Reduction and Biomarkers
Measure Name

Perception of Tobacco Product Risk

Release Date

February 23, 2021

Definition

Instrument used to assess respondents’ perception of how much they think people risk harming themselves by using tobacco products and the relative health risk between low-risk products and combustible cigarettes.

Purpose

The purpose of this measure is to collect information from respondents on their thoughts about the physical and health risk associated with using tobacco products. Perceptions of risk of tobacco products are important in predicting first use and continued use.

Keywords

Perceived harm, perceived risk, product risk, Population Assessment of Tobacco and Health, PATH, National Institutes of Health, NIH, U.S. Food and Drug Administration, FDA, Smoking Cessation, Harm Reduction, and Biomarkers, cigarettes, tobacco, e-cigarettes, cigars, pipe tobacco, smokeless tobacco

Measure Protocols
Protocol ID Protocol Name
330501 Perception of Tobacco Product Risk - Cigarettes
330502 Perception of Tobacco Product Risk - E-Cigarettes
330503 Perception of Tobacco Product Risk - Cigars
330504 Perception of Tobacco Product Risk - Pipe Tobacco
330505 Perception of Tobacco Product Risk - Smokeless Tobacco
Publications

There are no publications listed for this protocol.